EcoDrugPlus

Endothelin Converting Enzyme 1

Ensembl ID : ENSPVAG00000004633
Gene Symbol: ECE1
1 Cross references
229 Possible Orthologues:

Endothelin Receptor Type A

Ensembl ID : ENSPVAG00000010898
Gene Symbol: EDNRA
1 Cross references
265 Possible Orthologues:

Endothelin Receptor Type B

Ensembl ID : ENSPVAG00000000596
Gene Symbol: EDNRB
1 Cross references
264 Possible Orthologues:

Enhancer Of Zeste 2 Polycomb Repressive Complex 2 Subunit

Ensembl ID : ENSPVAG00000009107
Gene Symbol: EZH2
1 Cross references
222 Possible Orthologues:

Epidermal Growth Factor Receptor

Ensembl ID : ENSPVAG00000011454
Gene Symbol: EGFR
1 Cross references
285 Possible Orthologues:

Epoxide Hydrolase 2

Ensembl ID : ENSPVAG00000006063
Gene Symbol: EPHX2
1 Cross references
203 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 2

Ensembl ID : ENSPVAG00000008524
Gene Symbol: ERBB2
1 Cross references
200 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 3

Ensembl ID : ENSPVAG00000007560
Gene Symbol: ERBB3
1 Cross references
282 Possible Orthologues:

Erb-B2 Receptor Tyrosine Kinase 4

Ensembl ID : ENSPVAG00000007780
Gene Symbol: ERBB4
1 Cross references
236 Possible Orthologues:

Estrogen Receptor 1

Ensembl ID : ENSPVAG00000001923
Gene Symbol: ESR1
1 Cross references
211 Possible Orthologues:

Estrogen Receptor 2

Ensembl ID : ENSPVAG00000017577
Gene Symbol: ESR2
1 Cross references
273 Possible Orthologues:

Estrogen Related Receptor Gamma

Ensembl ID : ENSPVAG00000008613
Gene Symbol: ESRRG
1 Cross references
277 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).